Correlation Between ProShares and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both ProShares and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProShares and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProShares SP 500 and Inozyme Pharma, you can compare the effects of market volatilities on ProShares and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProShares with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProShares and Inozyme Pharma.
Diversification Opportunities for ProShares and Inozyme Pharma
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ProShares and Inozyme is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding ProShares SP 500 and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and ProShares is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProShares SP 500 are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of ProShares i.e., ProShares and Inozyme Pharma go up and down completely randomly.
Pair Corralation between ProShares and Inozyme Pharma
Given the investment horizon of 90 days ProShares is expected to generate 115.6 times less return on investment than Inozyme Pharma. But when comparing it to its historical volatility, ProShares SP 500 is 15.65 times less risky than Inozyme Pharma. It trades about 0.02 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 96.00 in Inozyme Pharma on March 26, 2025 and sell it today you would earn a total of 303.00 from holding Inozyme Pharma or generate 315.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.39% |
| Values | Daily Returns |
ProShares SP 500 vs. Inozyme Pharma
Performance |
| Timeline |
| ProShares SP 500 |
| Inozyme Pharma |
ProShares and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProShares and Inozyme Pharma
The main advantage of trading using opposite ProShares and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProShares position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| ProShares vs. FT Vest Equity | ProShares vs. Northern Lights | ProShares vs. Dimensional International High | ProShares vs. JPMorgan Fundamental Data |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |